Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Clinical Outcomes and Mutational Profile Associated with Dysmyelopoiesis in Chronic Myelomonocytic Leukemia

Xavier Calvo, David Román, Nieves Garcia Garcia-Gisbert, Concepción Fernández-Rodriguez, Marta Salido, Anna Puiggros, Blanca Espinet, Sara Garcia-Avila, Félix López Cadenas, Abora Rial-Villavecchia, Luis Colomo, Lourdes Florensa, Ana Ferrer, Leonor Arenillas

Blood (2023) 142 (Supplement 1): 3226.

https://doi.org/10.1182/blood-2023-185591

Published: 2023

Journal Articles

Chronic Myelomonocytic Leukemia (CMML) with AML Typical Mutations ( NPM1, FLT3 or CEBPA ) Identify a High-Risk CMML Group Independent of Molecular-Cpss

Blood (2023) 142 (Supplement 1): 3231.

https://doi.org/10.1182/blood-2023-173311

Published: 2023

Journal Articles

Identification of Three Unique Clusters of Serum Proteins with Distinctive Functionalities in IGHV-Mutated MBL

Gonzalo Blanco, Florencia Palacios, Kamala Vanarsa, Poojitha Dugyala, Pui Yan Chiu, Steven L Allen, Yasmine Kieso, Anna Puiggros, Jacqueline C. Barrientos, Xavier Calvo, Jonathan E. Kolitz, Eva Gimeno, Joanna M. Rhodes, Ana Ferrer, Kanti R Rai, Barbara Sherry, Blanca Espinet, Chandra Mohan, Nicholas Chiorazzi

Blood (2022) 140 (Supplement 1): 9859–9861.

https://doi.org/10.1182/blood-2022-169722

Published: 2022

Journal Articles

Myelodysplastic Syndromes Presenting with Isolated Thrombocytopenia: A Less Aggressive Form of Presentation and with Better Prognosis

Marie Solange Flores-Moran, Leonor Arenillas, Ana Ferrer, Felix Lopez-Cadenas, Sara Garcia-Avila, Concepción Fernández, Antonio Salar, Xavier Calvo

Blood (2022) 140 (Supplement 1): 6960–6961.

https://doi.org/10.1182/blood-2022-167567

Published: 2022

Journal Articles

Assessment of Dysgranulopoiesis By Optical Cytology Compared to Distribution of Monocyte Subsets By Flow Cytometry in Peripheral Blood for Predicting the Diagnosis of CMML

David Roman-Bravo, Leonor Arenillas, Aylin Vasquez, Lourdes Florensa, Beatriz Costan, Rosa Navarro, Martina Karasiewicz, Sara Garcia-Avila, Felix Lopez-Cadenas, Marta Salido, Anna Puiggros, Blanca Espinet, Ana Ferrer, Xavier Calvo

Blood (2022) 140 (Supplement 1): 12347–12348.

https://doi.org/10.1182/blood-2022-166229

Published: 2022

Journal Articles

Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes

Nieves Garcia-Gisbert, Brayan Merchan, Sara Garcia-Avila, Marta Salido, Concepción Fernández-Rodríguez, Joan Gibert, Lierni Fernández-Ibarrondo, Laura Camacho, Marta Lafuente, Raquel Longarón, Blanca Espinet, Patricia Vélez, Marcio M Andrade-Campos, Ramon M. Pujol, Leonor Arenillas, Xavier Calvo, Carles Besses, Antonio Salar, Beatriz Bellosillo

Blood (2021) 138 (Supplement 1): 2599.

https://doi.org/10.1182/blood-2021-148297

Published: 2021

Journal Articles

Serum Proteomic Analyses Suggest That the HMGB1 and Other Inflammatory Pathways Are Operational in MBL and Are Less in Overt CLL

Florencia Palacios, Gonzalo Blanco, Kamala Vanarsa, Poojitha Dugyala, Steven L Allen, Yasmine Kieso, Anna Puiggros, Jacqueline Barrientos, Xavier Calvo, Jonathan E Kolitz, Eva Gimeno, Joanna M Rhodes, ANA Ferrer, Kanti R Rai, Blanca Espinet, Chandra Mohan, Nicholas Chiorazzi

Blood (2021) 138 (Supplement 1): 2625.

https://doi.org/10.1182/blood-2021-152514

Published: 2021

Journal Articles

Early Immune Profile Assessment By Flow Cytometry Predicts Severe COVID-19 Pneumonia

Abora Rial-Villavecchia, Maria Teresa Asensi, Carme Giménez-Argente, Joan Gómez-Junyent, Juan Jose Rodriguez-Sevilla, Leonor Arenillas, Ana Ferrer, Eloi García-Vives, Jaime Rodriguez-Morera, Jade Soldado-Folgado, Xavier Calvo

Blood (2021) 138 (Supplement 1): 4197.

https://doi.org/10.1182/blood-2021-151282

Published: 2021

Journal Articles

Multiple TET2 Mutations As a New Biological Clue for Differentiating Oligomonocytic Chronic Myelomonocytic Leukemia from Myelodysplastic Syndromes

Nieves Garcia-Gisbert, Leonor Arenillas, David Roman-Bravo, Juan José Rodríguez-Sevilla, Brayan Merchan, Sara Garcia-Avila, Concepción Fernández-Rodríguez, Joan Gibert, Antonio Salar, Beatriz Bellosillo, Ana Ferrer, Xavier Calvo

Blood (2021) 138 (Supplement 1): 1530.

https://doi.org/10.1182/blood-2021-152674

Published: 2021

Journal Articles

Clinical Outcomes of Oligomonocytic Chronic Myelomonocytic Leukemia (OM-CMML) and Predictive Factors of Evolution of OM-CMML into Overt Chronic Myelomonocytic Leukemia (CMML)

David Roman-Bravo, Leonor Arenillas, Maria Teresa Asensi, Nieves Garcia-Gisbert, Juan Jose Rodriguez-Sevilla, Brayan Merchan, Sara García Ávila, Beatriz Bellosillo, Concepción Fernández-Rodríguez, Lourdes Florensa, Ana Ferrer, Xavier Calvo

Blood (2021) 138 (Supplement 1): 1533.

https://doi.org/10.1182/blood-2021-146447

Published: 2021

Journal Articles

Clinical Interest of LMO2 Testing in Aggressive Large B-Cell Lymphomas

Luis Colomo, Ivonne Vazquez, Natalia Papaleo, Marta Salido, Anna Puiggros, Blanca Espinet, Maria Rodriguez-Rivera, Ramon Diez-Feijoo, Blanca Sanchez-Gonzalez, Antonio Salar, Ana Ferrer, Leonor Arenillas, Marcio Andrade Campos, MD PhD, Xavier Calvo

Blood (2019) 134 (Supplement_1): 2899.

https://doi.org/10.1182/blood-2019-125717

Published: 2019

Journal Articles

Gene Expression and Cytokine Analyses Identify Markers of Progression from CLL-like Monoclonal B-Cell Lymphocytosis to Chronic Lymphocytic Leukemia

Gonzalo Blanco, PhD, Anna Puiggros, PhD, Barbara Sherry, PhD, Lara Nonell, Eulalia Puigdecanet, Pui Yan Chiu, Yasmine Kieso, MSCR, Gerardo Ferrer, PhD, Magdalena Arnal, María Rodríguez-Rivera, Eva Gimeno, MD PhD, Eugenia Abella, Kanti R Rai, MD, Pau Abrisqueta, MD PhD, Xavier Calvo, MD PhD, Francesc Bosch, MD PhD, Ana Ferrer, MD PhD, Nicholas Chiorazzi, MD, Blanca Espinet, PhD

Blood (2019) 134 (Supplement_1): 3027.

https://doi.org/10.1182/blood-2019-122038

Published: 2019

Journal Articles

Deciphering the CXCL9-CXCL10-CXCL11/CXCR3 Axis in CLL-like Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia: A New Target for Immune Activation?

Gonzalo Blanco, PhD, Anna Puiggros, PhD, Barbara Sherry, PhD, Lara Nonell, Xavier Calvo, MD PhD, Eulalia Puigdecanet, Pui Yan Chiu, Yasmine Kieso, MSCR, Gerardo Ferrer, PhD, Magdalena Arnal, María Rodríguez-Rivera, Eva Gimeno, MD PhD, Eugenia Abella, Kanti R Rai, MD, Pau Abrisqueta, MD PhD, Francesc Bosch, MD PhD, Ana Ferrer, MD PhD, Nicholas Chiorazzi, MD, Blanca Espinet, PhD

Blood (2019) 134 (Supplement_1): 3029.

https://doi.org/10.1182/blood-2019-122061

Published: 2019

Journal Articles

Molecular Characterization of Ph-Negative Myeloproliferative Neoplasms in Tumor Circulating Nucleic Acids

Nieves Garcia-Gisbert, MSc, Lierni Fernández-Ibarrondo, Concepción Fernández-Rodríguez, Laura Camacho, Anna Angona, MD PhD, Joan Gibert, PhD, Xavier Calvo, MD PhD, Leonor Arenillas, MD PhD, Raquel Longarón, Marcio Andrade, MD PhD, Antonio Salar, MD PhD, Carles Besses, MD PhD, Beatriz Bellosillo, PhD

Blood (2019) 134 (Supplement_1): 2953.

https://doi.org/10.1182/blood-2019-123003

Published: 2019

Journal Articles

Reduced Expression of the CD94/NKG2C NK Cell Receptor in Chronic Lymphocytic Leukemia (CLL) and CLL-like Monoclonal B-Cell Lymphocytosis (MBL)

Anna Puiggros, PhD, Gonzalo Blanco, PhD, Aura Muntasell, María Rodríguez-Rivera, Lara Nonell, Eulalia Puigdecanet, Magdalena Arnal, Xavier Calvo, MD PhD, Eva Gimeno, MD PhD, Eugenia Abella, Pau Abrisqueta, MD PhD, Francesc Bosch, MD PhD, José Yélamos, Ana Ferrer, MD PhD, Miguel Lopez-Botet, Blanca Espinet, PhD

Blood (2019) 134 (Supplement_1): 5457.

https://doi.org/10.1182/blood-2019-128055

Published: 2019

Journal Articles

High Diagnostic Utility of Flow Cytometry Based Peripheral Blood Monocyte Subset Analysis, CD56 and CD2 Expression in Chronic Myelomonocytic Leukemia (CMML)

Xavier Calvo, MD PhD, Ivonne Parraga, Fellow, Nieves Garcia-Gisbert, MSc, Lourdes Florensa, MD PhD, Sara Montesdeoca, MD, Concepción Fernández, Marta Salido, PhD, Anna Puiggros, PhD, Blanca Espinet, PhD, Beatriz Bellosillo, PhD, Lluís Colomo, MD PhD, David Roman, MD, Marcio Andrade Campos, MD PhD, Brayan Merchan, MD MSc, Ana Ferrer, MD PhD, Leonor Arenillas, MD PhD

Blood (2019) 134 (Supplement_1): 5437.

https://doi.org/10.1182/blood-2019-130499

Published: 2019

Journal Articles

Altered Immunophenotypes on Leukemic and/or Monocytic Cells from Acute Myeloid Leukemia Highly Predict for Nucleophosmin Gene Mutation

Blood (2019) 134 (Supplement_1): 2687.

https://doi.org/10.1182/blood-2019-131733

Published: 2019

Journal Articles

Generation of a New Prognostic Index for Chronic Myelomonocytic Leukemia (CMML) Based on Peripheral Blood Assessment

David Roman, MD, Leonor Arenillas, MD PhD, Ivonne Parraga, Fellow, Lourdes Florensa, MD PhD, Sara Montesdeoca, MD, Marta Salido, PhD, Puiggros Anna, Blanca Espinet, PhD, Lluís Colomo, MD PhD, Marcio Andrade, MD PhD, Brayan Merchan, MD MSc, Ana Ferrer, MD PhD, Xavier Calvo, MD PhD

Blood (2019) 134 (Supplement_1): 4262.

https://doi.org/10.1182/blood-2019-128768

Published: 2019

Journal Articles

Clinical Characteristics and Cardioavscular Events in Patients with Esential Thrombocythemia with <10% Vs. ≥10% JAK2 V617F Allele Burden

Blood (2019) 134 (Supplement_1): 4171.

https://doi.org/10.1182/blood-2019-126980

Published: 2019

Journal Articles

Oligomonocytic Chronic Myelomonocytic Leukemia (O-CMML) and Chronic Myelomonocytic Leukemia (CMML) Show Similar Clinical, Morphological, Immunophenotypic and Molecular Features

Xavier Calvo, MD PhD, Nieves Garcia-Gisbert, MSc, Ivonne Parraga, Fellow, Lourdes Florensa, MD PhD, Sara Montesdeoca, MD, Concepción Fernández, Marta Salido, PhD, Anna Puiggros, PhD, Blanca Espinet, PhD, Beatriz Bellosillo, PhD, Lluís Colomo, MD PhD, David Roman, MD, Marcio Andrade, MD PhD, Brayan Merchan, MD MSc, Ana Ferrer, MD PhD, Leonor Arenillas, MD PhD

Blood (2019) 134 (Supplement_1): 4266.

https://doi.org/10.1182/blood-2019-130445

Published: 2019

NARROW

Clinical Outcomes and Mutational Profile Associated with Dysmyelopoiesis in Chronic Myelomonocytic Leukemia

Chronic Myelomonocytic Leukemia (CMML) with AML Typical Mutations ( NPM1, FLT3 or CEBPA ) Identify a High-Risk CMML Group Independent of Molecular-Cpss

Identification of Three Unique Clusters of Serum Proteins with Distinctive Functionalities in IGHV-Mutated MBL

Myelodysplastic Syndromes Presenting with Isolated Thrombocytopenia: A Less Aggressive Form of Presentation and with Better Prognosis

Assessment of Dysgranulopoiesis By Optical Cytology Compared to Distribution of Monocyte Subsets By Flow Cytometry in Peripheral Blood for Predicting the Diagnosis of CMML

Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes

Serum Proteomic Analyses Suggest That the HMGB1 and Other Inflammatory Pathways Are Operational in MBL and Are Less in Overt CLL

Early Immune Profile Assessment By Flow Cytometry Predicts Severe COVID-19 Pneumonia

Multiple TET2 Mutations As a New Biological Clue for Differentiating Oligomonocytic Chronic Myelomonocytic Leukemia from Myelodysplastic Syndromes

Clinical Outcomes of Oligomonocytic Chronic Myelomonocytic Leukemia (OM-CMML) and Predictive Factors of Evolution of OM-CMML into Overt Chronic Myelomonocytic Leukemia (CMML)

Clinical Interest of LMO2 Testing in Aggressive Large B-Cell Lymphomas

Gene Expression and Cytokine Analyses Identify Markers of Progression from CLL-like Monoclonal B-Cell Lymphocytosis to Chronic Lymphocytic Leukemia

Deciphering the CXCL9-CXCL10-CXCL11/CXCR3 Axis in CLL-like Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia: A New Target for Immune Activation?

Molecular Characterization of Ph-Negative Myeloproliferative Neoplasms in Tumor Circulating Nucleic Acids

Reduced Expression of the CD94/NKG2C NK Cell Receptor in Chronic Lymphocytic Leukemia (CLL) and CLL-like Monoclonal B-Cell Lymphocytosis (MBL)

High Diagnostic Utility of Flow Cytometry Based Peripheral Blood Monocyte Subset Analysis, CD56 and CD2 Expression in Chronic Myelomonocytic Leukemia (CMML)

Altered Immunophenotypes on Leukemic and/or Monocytic Cells from Acute Myeloid Leukemia Highly Predict for Nucleophosmin Gene Mutation

Generation of a New Prognostic Index for Chronic Myelomonocytic Leukemia (CMML) Based on Peripheral Blood Assessment

Clinical Characteristics and Cardioavscular Events in Patients with Esential Thrombocythemia with <10% Vs. ≥10% JAK2 V617F Allele Burden

Oligomonocytic Chronic Myelomonocytic Leukemia (O-CMML) and Chronic Myelomonocytic Leukemia (CMML) Show Similar Clinical, Morphological, Immunophenotypic and Molecular Features

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only